Literature DB >> 20427217

Prediction of passive blood-brain partitioning: straightforward and effective classification models based on in silico derived physicochemical descriptors.

Santiago Vilar1, Mayukh Chakrabarti, Stefano Costanzi.   

Abstract

The distribution of compounds between blood and brain is a very important consideration for new candidate drug molecules. In this paper, we describe the derivation of two linear discriminant analysis (LDA) models for the prediction of passive blood-brain partitioning, expressed in terms of logBB values. The models are based on computationally derived physicochemical descriptors, namely the octanol/water partition coefficient (logP), the topological polar surface area (TPSA) and the total number of acidic and basic atoms, and were obtained using a homogeneous training set of 307 compounds, for all of which the published experimental logBB data had been determined in vivo. In particular, since molecules with logBB>0.3 cross the blood-brain barrier (BBB) readily while molecules with logBB<-1 are poorly distributed to the brain, on the basis of these thresholds we derived two distinct models, both of which show a percentage of good classification of about 80%. Notably, the predictive power of our models was confirmed by the analysis of a large external dataset of compounds with reported activity on the central nervous system (CNS) or lack thereof. The calculation of straightforward physicochemical descriptors is the only requirement for the prediction of the logBB of novel compounds through our models, which can be conveniently applied in conjunction with drug design and virtual screenings. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20427217      PMCID: PMC2873098          DOI: 10.1016/j.jmgm.2010.03.010

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  26 in total

1.  Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration.

Authors:  D E Clark
Journal:  J Pharm Sci       Date:  1999-08       Impact factor: 3.534

2.  Prediction of the brain-blood distribution of a large set of drugs from structurally derived descriptors using partial least-squares (PLS) modeling.

Authors:  J M Luco
Journal:  J Chem Inf Comput Sci       Date:  1999 Mar-Apr

3.  Understanding and circumventing the blood-brain barrier.

Authors:  D J Begley
Journal:  Acta Paediatr Suppl       Date:  2003-12

4.  Theoretical calculation and prediction of brain-blood partitioning of organic solutes using MolSurf parametrization and PLS statistics.

Authors:  U Norinder; P Sjöberg; T Osterberg
Journal:  J Pharm Sci       Date:  1998-08       Impact factor: 3.534

5.  On the partition of ampholytes: application to blood-brain distribution.

Authors:  M H Abraham; K Takács-Novák; R C Mitchell
Journal:  J Pharm Sci       Date:  1997-03       Impact factor: 3.534

6.  In silico prediction of blood brain barrier permeability: an Artificial Neural Network model.

Authors:  Prabha Garg; Jitender Verma
Journal:  J Chem Inf Model       Date:  2006 Jan-Feb       Impact factor: 4.956

7.  Computation of brain-blood partitioning of organic solutes via free energy calculations.

Authors:  F Lombardo; J F Blake; W J Curatolo
Journal:  J Med Chem       Date:  1996-11-22       Impact factor: 7.446

8.  Potential of biopartitioning micellar chromatography as an in vitro technique for predicting drug penetration across the blood-brain barrier.

Authors:  L Escuder-Gilabert; M Molero-Monfort; R M Villanueva-Camañas; S Sagrado; M J Medina-Hernández
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-08-05       Impact factor: 3.205

9.  Hydrogen bonding. 33. Factors that influence the distribution of solutes between blood and brain.

Authors:  M H Abraham; H S Chadha; R C Mitchell
Journal:  J Pharm Sci       Date:  1994-09       Impact factor: 3.534

10.  Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides.

Authors:  E G Chikhale; K Y Ng; P S Burton; R T Borchardt
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200

View more
  31 in total

1.  DemQSAR: predicting human volume of distribution and clearance of drugs.

Authors:  Ozgur Demir-Kavuk; Jörg Bentzien; Ingo Muegge; Ernst-Walter Knapp
Journal:  J Comput Aided Mol Des       Date:  2011-11-20       Impact factor: 3.686

2.  CNS Anticancer Drug Discovery and Development Conference White Paper.

Authors:  Victor A Levin; Peter J Tonge; James M Gallo; Marc R Birtwistle; Arvin C Dar; Antonio Iavarone; Patrick J Paddison; Timothy P Heffron; William F Elmquist; Jean E Lachowicz; Ted W Johnson; Forest M White; Joohee Sul; Quentin R Smith; Wang Shen; Jann N Sarkaria; Ramakrishna Samala; Patrick Y Wen; Donald A Berry; Russell C Petter
Journal:  Neuro Oncol       Date:  2015-11       Impact factor: 12.300

Review 3.  Physiologically based pharmacokinetic modelling of drug penetration across the blood-brain barrier--towards a mechanistic IVIVE-based approach.

Authors:  Kathryn Ball; François Bouzom; Jean-Michel Scherrmann; Bernard Walther; Xavier Declèves
Journal:  AAPS J       Date:  2013-06-20       Impact factor: 4.009

Review 4.  Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.

Authors:  Sagar Agarwal; Ramola Sane; Rajneet Oberoi; John R Ohlfest; William F Elmquist
Journal:  Expert Rev Mol Med       Date:  2011-05-13       Impact factor: 5.600

Review 5.  Permeability of the Blood-Brain Barrier: Molecular Mechanism of Transport of Drugs and Physiologically Important Compounds.

Authors:  Clifford W Fong
Journal:  J Membr Biol       Date:  2015-02-13       Impact factor: 1.843

6.  Qualitative prediction of blood-brain barrier permeability on a large and refined dataset.

Authors:  Markus Muehlbacher; Gudrun M Spitzer; Klaus R Liedl; Johannes Kornhuber
Journal:  J Comput Aided Mol Des       Date:  2011-11-23       Impact factor: 3.686

7.  Developing Enhanced Blood-Brain Barrier Permeability Models: Integrating External Bio-Assay Data in QSAR Modeling.

Authors:  Wenyi Wang; Marlene T Kim; Alexander Sedykh; Hao Zhu
Journal:  Pharm Res       Date:  2015-04-11       Impact factor: 4.200

8.  Improved Prediction of Blood-Brain Barrier Permeability Through Machine Learning with Combined Use of Molecular Property-Based Descriptors and Fingerprints.

Authors:  Yaxia Yuan; Fang Zheng; Chang-Guo Zhan
Journal:  AAPS J       Date:  2018-03-21       Impact factor: 4.009

Review 9.  Deriving therapies for children with primary CNS tumors using pharmacokinetic modeling and simulation of cerebral microdialysis data.

Authors:  M O Jacus; S L Throm; D C Turner; Y T Patel; B B Freeman; M Morfouace; N Boulos; C F Stewart
Journal:  Eur J Pharm Sci       Date:  2013-11-20       Impact factor: 4.384

10.  Evaluation of the behavioral and pharmacokinetic profile of SYA013, a homopiperazine analog of haloperidol in rats.

Authors:  Barbara Bricker; Tanise Jackson; Bernard Boateng; Xue Y Zhu; Seth Y Ablordeppey
Journal:  Pharmacol Biochem Behav       Date:  2012-05-12       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.